Low-dose salinomycin induces anti-leukemic responses in AML and MLL

Development of anti-cancer drugs towards clinical application is costly and inefficient. Large screens of drugs, efficacious for non-cancer disease, are currently being used to identify candidates for repurposing based on their anti-cancer properties. Here, we show that low-dose salinomycin, a cocci...

Descripción completa

Detalles Bibliográficos
Autores principales: Roulston, Gary D.R., Burt, Charlotte L., Kettyle, Laura M.J., Matchett, Kyle B., Keenan, Heather L., Mulgrew, Nuala M., Ramsey, Joanne M., Dougan, Caoifa, McKiernan, John, Grishagin, Ivan V., Mills, Ken I., Thompson, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341990/
https://www.ncbi.nlm.nih.gov/pubmed/27612428
http://dx.doi.org/10.18632/oncotarget.11866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341990/
https://www.ncbi.nlm.nih.gov/pubmed/27612428
http://dx.doi.org/10.18632/oncotarget.11866

Ejemplares similares